The Burrill Report
The Burrill Report (February 10, 2014): NIH's Collins Discusses Partnership with Industry(.MP3,14.07 Mb)
The National Institutes of Health, along with a group of top drug companies and non profits, announced the launch of the Accelerating Medicines Partnership, an effort to join forces to identify and validate promising biological targets for drugs. The program, backed with $230 million over five years, hopes to accelerate the development and reduce the cost of bringing needed drugs to market. We spoke to NIH Director Francis Collins about the program, what it took to get competitors to collaborate, and why he hopes the benefits of this approach will extend far beyond the diseases being targeted.
February 06, 2014